2 assets in Apocrine Adenocarcinoma

Therapeutic assets addressing Apocrine Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Apocrine Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Nivolumab Apocrine Adenocarcinoma	Instituto do Cancer do Estado de São Paulo	P2	CCC (53)